Application of Fluorescence in situ Hybridization in Malignant Hemopathies: First Experience from Albania
By: D Roko, A Babameto-Laku, A Perolla and E Calliku
References
- Ngo Sack Françoise, Lontsi Sonkwa Edgard, Chetcha Tchemegni Bernard. Clinical, biological, therapeutic and evolving profile of malignant hemopathies in adults at the central hospital of Yaounde. JMR 2021; ISSN:2395-7565.
- Sevgi Gezici Molecular Mechanisms of Immune Checkpoints as an Immunotherapy Tool in Hematological Malignancies. Comprehensive Hematology and Stem Cell Research, 2024, 366–372.
- Radhakrishnan Ramchandren, Tarek Jazaerly, Ali M. Gabali. Molecular Diagnosis of Hematopoietic Neoplasms. Clin Lab Med, 2013, 33(4):817–833.
- Mi-Ae Jang. Genomic technologies for detecting structural variations in hematologic malignancies. Blood Res, 2024 Feb 13;59(1):1.
- T H Lim, S L Tien, P Lim, A S T Lim. The incidence and patterns of BCR/ABL rearrangements in chronic myeloid leukaemia (CML) using fluorescence in situ hybridisation Ann Acad Med Singap 2005 Oct;34(9):533–8. DOI:10.18632/oncotarget.15369 Corpus ID: 3671430.
- Bibi Tahira, Muhammad Asif, Samiullah Khan, Abrar Hussain, Muhammad Naeem Shahwani, Arif Malik et.al; Detection of BCR/ABL Fusion Gene by Hematological and Cytogenetical Analysis in Chronic Myeloid Leukemia Patients in Quetta, Pakistan Asian Pac J Cancer Prev 2015;16(9):3793–7 doi: 10.7314/apjcp.2015.16.9.3793.
- Hossein Rahimi, Mohammad Hadi Sadeghian, Mohammad Reza Keramati, Amir Hossein Jafarian, Sepideh Shakeri, Seyyede Fatemeh Shams et.al; Cytogenetic Abnormalities with Interphase FISH Method and Clinical Manifestation in Chronic Lymphocytic Leukemia Patients in North-East of Iran Int J Hematol Oncol Stem Cell Res 2017 Jul 1;11(3):217–224.
- V. Buccheri, W. Barreto, L. Fogliatto, M. Capra, Mariana Marchiani, V. Rocha Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation Annals of Hematology 12 October 2018 DOI: 10.1007/s00277-018-3503-6 Corpus ID: 52975190.
- Patricia T Greipp, Stephanie A Smoley, David S Viswanatha, Lori S Frederick, Kari G Rabe, Ruchi G Sharma, et.al; Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis Br J Haematol 2013 Nov;163(3):326–33. doi: 10.1111/bjh.12534.
- Elias Campo, Florence Cymbalista, Paolo Ghia, Ulrich Jäger, Sarka Pospisilova, Richard Rosenquist et.al; TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics Haematologica 2018 Nov 15;103(12):1956–1968. doi: 10.3324/haematol.2018.187583.
- Marie-France Gagnon, Holly E Berg, Reid G Meyer, William R Sukov, Daniel L Van Dyke, Robert B Jenkins et.al; Typical, atypical and cryptic t(15;17) (q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: A retrospective review of 831 patients with concurrent chromosome and PML::RARA dual-color dual-fusion FISH studies Genes Chromosomes Cancer 2022 Oct;61(10):629–634. doi: 10.1002/gcc.23070.
- Maedeh Mohebnasab, Peng Li, Bo Hong, Jennifer Dunlap, Elie Traer, Guang Fan et. al; Cytogenetically Cryptic Acute Promyelocytic Leukemia: A Diagnostic Challenge Int J Mol Sci 2023 Aug 22;24(17):13075. doi: 10.3390/ijms241713075.
- Rimvydas Norvilas, Vaidas Dirse, Ruta Semaskeviciene, Orinta Mickeviciute, Egle Gineikiene et, al: Low incidence of ABL-class and JAK-STAT signaling pathway alterations in uniformly treated pediatric and adult B-cell acute lymphoblastic leukemia patients using MRD risk-directed approach - a population-based study BMC Cancer, 2021 Mar 29;21(1):326. doi: 10.1186/s12885-020-07781-6.
- Heim S. Cytogenetic findings in primary and secondary MDS. Leuk Res. 1992;16(1):43–6. doi: 10.1016/0145-2126(92)90098-r. PMID: 1732669
- Matteo Zampini, Elena Riva, Luca Lanino, Elisabetta Sauta, Rita Antunes Dos Reis et.al, Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes J Clin Oncol 43, 2069–2083(2025), Volume 43, Number DOI: 10.1200/JCO-24-02394.
- Ugo Testa, Germana Castelli, Elvira Pelosi Clinical and Biological Insights into Myelodysplastic Neoplasms Associated with Deletions of Chromosome 5q Region Hematol. Rep. 2025, 17(6), 67;
https://doi.org/10.3390/hematolrep17060067 . - Hatice Deniz Gur, Sa A. Wang, Zhenya Tang, Shimin Hu, Shaoying Li et.al; Clinical significance of isolated del(7p) in myeloid neoplasms Leukemia Research, Volume 55, April 2017, Pages 18–22 January 2017
https://doi.org/10.1016/j.leukres.2017.01.016 . - Sandra Huber, Stephan Hutter, Constance Baer, Manja Meggendorfer, Gregor Hoermann, Wolfgang Kern, et.al; Two ways to complex karyotype in MDS—the role of del(5q) and TP53 Blood (2024) 144 (Supplement 1): 1836.
https://doi.org/10.1182/blood-2024-201270 . - Manoela M Ortega, Monica Barbosa De Melo, Carmino A. Souza, Lima Carmen S. Passos Lima, P53 gene deletion in multiple myeloma June 2003 Revista Brasileira de Hematologia e Hemoterapia 25(2) DOI: 10.1590/S1516-84842003000200014 .
- M. Martello, A. Poletti, E. Borsi, V. Solli, L. Dozza, S. Barbato, et al Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma Blood Cancer J 2022 Jan 26;12(1):15. doi: 10.1038/s41408-022-00610-y.
- Seiichiro Katagiri, Daigo Akahane, Kunihiko Takeyama, Norihide Sato, Nobuyuki Takayama, Jun Ando, et al. TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy Annals of Hematology (2025) 104:1801–1806
https://doi.org/10.1007/s00277-025-06297-y .
DOI: https://doi.org/10.2478/bjmg-2026-0006 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Language: English
Page range: 33 - 38
Published on: Oct 14, 2026
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 D Roko, A Babameto-Laku, A Perolla, E Calliku, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution 4.0 License.